Drospirenone (DROP) is a highly effective, low-toxicity, safe new generation progestin that counteracts estrogen-related sodium retention, is well tolerated, and has a positive effect on premenstrual syndrome (PMS). However, the low water solubility of DROP and its chemical instability resulted in low bioavailability. In this study, we developed a two-step delivery system to enhance drospirenone’s solubility and stability. We prepared a drospirenone liposome complex to optimize the encapsulation process and achieve an encapsulation efficiency of (84.9 ± 0.73) %, with an 878-fold increase in solubility under optimal conditions. To address the instability of high drug-loading liposomes, we immobilized the drospirenone liposome inclusion complex using a cellulose-based hydrogel. The system achieved uniform loading of liposomes in the hydrogel, as confirmed by SEM and FTIR analysis. 0.5 g hydrogel can be loaded with up to 96.48 mg drospirenone, and the encapsulation efficiency is (80.4 ± 1.17%). It was indicating the potential for wider application of drospirenone with enhanced water solubility and improved stability. At the same time, it also provides support for sustained-release systems or large dose drug delivery.
PalaciosSRegidorPAColliE, et al.Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature. Eur J Contracept Reprod Health Care2020; 25: 221–227. DOI: 10.1080/13625187.2020.1743828.
2.
GenazzaniARMannellaPSimonciniT. Drospirenone and its antialdosterone properties. Climacteric2007; 10: 11–18. DOI: 10.1080/13697130601114891.
3.
KubbaAGemzell-DanielssonKPalaciosS, et al.The drospirenone (DRSP)-only pill: clinical implications in the daily use. Eur J Contracept Reprod Health Care2022; 28: 36–43. DOI: 10.1080/13625187.2022.2164186.
4.
TaoJWangJJiangW, et al.Serum hormone levels, T lymphocyte subsets, and achievement of pregnancies in patients with premature ovarian insufficiency following administration of ethinylestradiol/drospirenone. J Nanomater2021; 2021: 1–5. DOI: 10.1155/2021/9928051.
5.
RegidorPMuellerAMayrM. Women's health, 2023, pp. 17455057221147388. DOI: 10.1177/17455057221147388.
6.
PodfigurnaAMeczekalskiBPetragliaF, et al.Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone). J Endocrinol Invest2020; 43: 483–492. DOI: 10.1007/s40618-019-01133-3.
7.
BagatinERochaMFreitasTHP, et al.Treatment challenges in adult female acne and future directions. Expet Rev Clin Pharmacol2021; 14: 687–701. DOI: 10.1080/17512433.
8.
KrauseWKühneG. Isolation and identification of spirorenone metabolites from the monkey (Macaca fascicularis). Steroids1982; 40: 81–90. DOI: 10.1016/0039-128X(82)90114-3.
9.
Sitruk-WareR. Pharmacology of different progestogens: the special case of drospirenone. Climacteric2005; 8: 4–12. DOI: 10.1080/13697130500330382.
10.
StielowMWitczyńskaAKubryńN, et al.The bioavailability of drugs-the current state of knowledge. Molecules2023; 28: 8038. DOI: 10.3390/molecules28248038.
11.
TranPParkJS. Application of supercritical fluid technology for solid dispersion to enhance solubility and bioavailability of poorly water-soluble drugs. Int J Pharm2021; 610: 121247. DOI: 10.1016/j.ijpharm.2021.121247.
12.
RochaBDe MoraisLAVianaMC, et al.Promising strategies for improving oral bioavailability of poor water-soluble drugs. Expet Opin Drug Discov2023; 18: 615–627. DOI: 10.1080/17460441.2023.2211801.
13.
LaffleurFKeckeisV. Advances in drug delivery systems: work in progress still needed?Int J Pharm2020; 590: 119912. DOI: 10.1016/j.ijpharm.2020.119912.
14.
ZhaoJYangJXieY. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: an overview. Int J Pharm2019; 570: 118642. DOI: 10.1016/j.ijpharm.2019.118642.
15.
SchwarzDHEngelkeAWenzG. Solubilizing steroidal drugs by β-cyclodextrin derivatives. Int J Pharm2017; 531: 559–567. DOI: 10.1016/j.ijpharm.2017.07.046.
16.
WangXHXuJWangT. Enhancing the solubility and dose delivery of drospirenone through oxidized regenerated cellulose hydrogel compound with liposome system. J Drug Deliv Sci Technol2024; 94: 105507. DOI: 10.1016/j.jddst.2024.105507.
17.
LavradorPEstevesMRGasparVM, et al.Stimuli-responsive nanocomposite hydrogels for biomedical applications. Adv Funct Mater2020; 31: 8. DOI: 10.1002/adfm.202005941.
18.
GongFLiuJYangJ, et al.Effective thermal transport properties in multiphase biological systems containing carbon nanomaterials. RSC Adv2017; 7: 13615–13622. DOI: 10.1039/C6RA27768C.
19.
GongFDuongHMPapavassiliouDV. Review of recent developments on using an off-lattice Monte Carlo approach to predict the effective thermal conductivity of composite systems with complex structures. Nanomaterials2016; 6: 142. DOI: 10.3390/nano6080142.
20.
JesorkaAOrwarO. Liposomes: technologies and analytical applications. Annu Rev Anal Chem2008; 1: 801–832. DOI: 10.1146/annurev.anchem.1.031207.112747.
21.
BanghamADStandishMMWatkinsJC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol1965; 13: 238–252. DOI: 10.1016/s0022-2836(65)80093-6.
22.
AllenTMCullisPR. Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv2013; 65: 36–48. DOI: 10.1016/j.addr.2012.09.037.
23.
AkbarzadehARezaei-SadabadyRDavaranS, et al.Liposome: classification, preparation, and applications. Nanoscale Res Lett2013; 8: 102–109. DOI: 10.1186/1556-276X-8-102.
24.
HammoudZGharibRFourmentinS, et al.New findings on the incorporation of essential oil components into liposomes composed of lipoid S100 and cholesterol. Int J Pharm2019; 561: 161–170. DOI: 10.1016/j.ijpharm.2019.02.022.
25.
GregoriadisGRymanBE. Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem J1971; 124: 58. DOI: 10.1042/bj1240058p.
WongCWMetselaarJMStormG, et al.A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammation. Br J Ophthalmol2021; 105: 1617–1622. DOI: 10.1136/bjophthalmol-2020-315911.
28.
GallezAPalazzoCBlacherS, et al.Liposomes and drug-in-cyclodextrin-in-liposomes formulations encapsulating 17β-estradiol: an innovative drug delivery system that prevents the activation of the membrane-initiated steroid signaling (MISS) of estrogen receptor α. Int J Pharm2019; 573: 118861. DOI: 10.1016/j.ijpharm.2019.118861.
29.
El MaghrabyGMWilliamsACBarryBW. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm2004; 276: 143–161. DOI: 10.1016/j.ijpharm.2004.02.024.
30.
DeviKKYanaSAlexanderT. J Drug Deliv Sci Technol2018; 47: 275–282. DOI: 10.1016/j.jddst.2018.07.003.
31.
RanaDSalaveSJainS, et al.Systematic development and optimization of teriparatide-loaded nanoliposomes employing quality by design approach for osteoporosis. J Pharm Innov2023; 18: 548–562. DOI: 10.1007/s12247-022-09663-9.
32.
TangJSYangZYZhangY, et al.Preparation of PEGylated nedaplatin liposomes with sustained release behavior for enhancing the antitumor efficacy of non-small cell lung cancer. Int J Pharm2023; 635: 122708. DOI: 10.1016/j.ijpharm.2023.122708.
33.
TurjemanKYanayNElbazM, et al.Liposomal steroid nano-drug is superior to steroids as-is in mdx mouse model of Duchenne muscular dystrophy. Nanomedicine2019; 16: 34–44. DOI: 10.1016/j.nano.2018.11.012.
34.
TakkeAShendeP. Potential of cyclodextrin in hybrid liposomes for improving the solubility, bioavailability and stability of silibinin. Chem Pap2022; 76: 6579–6589. DOI: 10.1007/s11696-022-02345-3.
35.
ParkKHJungJYimS-G, et al.Mussel inspired surface acrylation on graphene oxide using acrylic surface primers and its hydrogel based applications: sustained drug release and tissue scaffolds. ChemistrySelect2020; 5: 5842–5849. DOI: 10.1002/slct.202000205.
36.
KhorsandiHKarimiARAzadikhahF. Preparation and evaluation of a sulfadimethoxine‐conjugated hydrogel based on N isopropylacrylamide as a sustained release drug delivery system. ChemistrySelect2022; 7. DOI: 10.1002/slct.202202428.
37.
LiBWangYWangZ, et al.Preparation and properties of hydrogels based on lignosulfonate and its efficiency of drug delivery. ChemistrySelect2021; 6: 8213–8218. DOI: 10.1002/slct.202101829.
38.
TiwariPVermaRBasuA, et al.Proteolysis resistant self assembled ω amino acid dipeptide based biocompatible hydrogels as drug delivery vehicle. ChemistrySelect2017; 2: 6623–6631. DOI: 10.1002/slct.201701172.
39.
LiQMaWMaH, et al.Synthesis and characterization of temperature‐/pH‐responsive hydrogels for drug delivery. ChemistrySelect2023; 8: 3. DOI: 10.1002/slct.202204270.
40.
ShakerSGardouhARGhorabMM. Factors affecting liposomes particle size prepared by ethanol injection method. Res Pharm Sci2017; 12: 346–352. DOI: 10.4103/1735-5362.213979.
41.
MaheshwariRBhattLKWairkarS. Enhanced oral bioavailability of progesterone in bilosome formulation: fabrication, statistical optimization, and pharmacokinetic study. AAPS PharmSciTech2024; 25: 29. DOI: 10.1208/s12249-024-02747-4.
42.
WangSChenYGuoJ, et al.Liposomes for tumor targeted therapy: a review. Int J Mol Sci2023; 24: 2643. DOI: 10.3390/ijms24032643.
43.
SalamaABadranMElmowafyM, et al.Spironolactone-loaded LeciPlexes as potential topical delivery systems for female acne: in vitro appraisal and ex vivo skin permeability studies. Pharmaceutics2019; 12: 25. DOI: 10.3390/pharmaceutics12010025.
44.
WangFAcevedoNMarangoniAG. Encapsulation of phytosterols and phytosterol esters in liposomes made with soy phospholipids by high pressure homogenization. Food Funct2017; 8: 3964–3969. DOI: 10.1039/c7fo00905d.
JinXYangHZhaoH, et al.Chem2022; 70: 5057–5065. DOI: 10.1021/acs.jafc.2c00236.
47.
MaritimSBoulasPLinY. Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes. Int J Pharm2021; 592: 120051. DOI: 10.1016/j.ijpharm.2020.120051.
48.
YiCFuMCaoX, et al.Enhanced oral bioavailability and tissue distribution of a new potential anticancer agent, Flammulina velutipes sterols, through liposomal encapsulation. J Agric Food Chem2013; 61: 5961–5971. DOI: 10.1021/jf3055278.
49.
HuJZhengYWenZ, et al.Construction of redox-sensitive liposomes modified by glycyrrhetinic acid and evaluation of anti-hepatocellular carcinoma activity. Chem Phys Lipids2023; 252: 105292. DOI: 10.1016/j.chemphyslip.2023.105292.
50.
NasutionHHarahapHDalimuntheNF, et al.Hydrogel and effects of crosslinking agent on cellulose-based hydrogels: a review. Gels2022; 8: 568. DOI: 10.3390/gels8090568.
51.
SallehKMZakariaSSajabMS, et al.Superabsorbent hydrogel from oil palm empty fruit bunch cellulose and sodium carboxymethylcellulose. Int J Biol Macromol2019; 131: 50–59. DOI: 10.1016/j.ijbiomac.2019.03.028.
52.
JinXWeiCWuC, et al.Gastric fluid-induced double network hydrogel with high swelling ratio and long-term mechanical stability. Compos Part B-Eng2022; 236: 109816. DOI: 10.1016/j.compositesb.2022.109816.
53.
SaddiqueACheongI. Recent advances in three-dimensional bioprinted nanocellulose-based hydrogel scaffolds for biomedical applications. Kor J Chem Eng2021; 38: 2171–2194. DOI: 10.1007/s11814-021-0926-x.
54.
ZhangYZhangRIllangakoonUE, et al.Copolymer composition and nanoparticle configuration enhance in vitro drug release behavior of poorly water-soluble progesterone for oral formulations. Int J Nanomed2020; 15: 5389–5403. DOI: 10.2147/ijn.s257353.
55.
JiangLHanYXuJ, et al.Preparation and study of cellulose-based ZnO NPs@HEC/C-β-CD/Menthol hydrogel as wound dressing. Biochem Eng J2022; 184: 108488. DOI: 10.1016/j.bej.2022.108488.
56.
KhushbuSGWThombareN. Isolation and identification of spirorenone. Polym Bull2022; 79: 2287–2303. DOI: 10.1007/s00289-021-03634-9.
